The report “Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Browse 84 market data tables and 65 figures spread through 184 pages and in-depth TOC on "Pre-Clinical Imaging Market”
Early buyers will receive 10% customization on this report.
This report studies the global preclinical imaging market over the forecast period of 2014 to 2019. The market is expected to reach $797 million by 2019, at CAGR of 6.0% from 2014 to 2019.
Based on modality, the global Pre-Clinical Imaging Market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and trimodality (PET/SPECT/CT) imaging systems.
Further Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=841
Bases on the reagents, the global Pre-Clinical Imaging Market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further subsegmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.
A number of factors such as technological advancements in molecular imaging modalities, rising adoption of multi-modality imaging systems in preclinical research studies, and growing acceptance of preclinical imaging in drug discovery and development processes are fuelling the demand of preclinical imaging systems and reagents. On the other hand, declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global Pre-Clinical Imaging Market.
As of 2014, North America holds the largest share of the global Pre-Clinical Imaging Market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2014 to 2019. A number of factors, including rising R&D activities by big pharma and biotech companies in developing nations, increased government funding for development of pharmaceutical industry, and growing number of CROs in emerging markets are stimulating the growth of the Pre-Clinical Imaging Market in the Asia-Pacific region. However, challenges associated with the application of radioisotopes, such as short half-life of PET radioisotopes and high cost involved in the generation of these isotopes, restricts the demand for micro-PET systems in developing Asian countries.
Speak with Research Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=841
Aspect Imaging (Israel), Biospace Lab S.A. (France), Bruker Corporation (U.S.), LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), PerkinElmer, Inc. (U.S.), TriFoil Imaging (U.S.), and FUJIFILM VisualSonics, Inc. (Canada) are the key players operating in the global preclinical imaging systems and reagents market.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets